Trademark: 90792277
Word
FLEXIBZUMAB
Status Date
Thursday, June 20, 2024
Filing Date
Thursday, June 24, 2021
Published for Opposition
Tuesday, April 26, 2022
5 Pharmaceutical preparations, namely, a drug delivery system comprising monoclonal antibodies for guiding therapeutic agents to a target tissue; therapeutic pharmaceutical for the treatment of cardiovascular diseases, high blood pressure, arteriosclerosis, aneurysms, diabetes, kidney diseases, and chronic obstructive pulmonary disease (COPD), the forgoing containing monoclonal antibodies; monoclonal antibodies for medical and veterinary purposes; monoclonal antibody preparations for therapeutic purposes; monoclonal antibodies for targeting drugs to calcified tissue for therapeutic purposes
Jun 28, 2021
New Application Entered
Sep 8, 2021
New Application Office Supplied Data Entered
Dec 8, 2021
Teas Voluntary Amendment Received
Dec 13, 2021
Assigned To Lie
Dec 13, 2021
Preliminary/Voluntary Amendment - Entered
Mar 16, 2022
Assigned To Examiner
Mar 22, 2022
Examiners Amendment -Written
Mar 22, 2022
Examiners Amendment E-Mailed
Mar 22, 2022
Notification Of Examiners Amendment E-Mailed
Mar 22, 2022
Examiner's Amendment Entered
Mar 22, 2022
Approved For Pub - Principal Register
Apr 6, 2022
Notification Of Notice Of Publication E-Mailed
Apr 26, 2022
Published For Opposition
Apr 26, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 21, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 13, 2022
Sou Teas Extension Received
Dec 13, 2022
Sou Extension 1 Filed
Dec 13, 2022
Sou Extension 1 Granted
Dec 15, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2023
Assignment Of Ownership Not Updated Automatically
Jun 20, 2023
Sou Teas Extension Received
Jun 20, 2023
Sou Extension 2 Filed
Jun 20, 2023
Sou Extension 2 Granted
Jun 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 12, 2023
Sou Teas Extension Received
Dec 12, 2023
Sou Extension 3 Filed
Dec 12, 2023
Sou Extension 3 Granted
Dec 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 20, 2024
Sou Teas Extension Received
Jun 20, 2024
Notice Of Approval Of Extension Request E-Mailed
Jun 20, 2024
Sou Extension 4 Granted
Jun 20, 2024
Sou Extension 4 Filed
Trademark Alertz updated from USPTO on 2030-01-24
